ZELTIQ Aesthetics, Inc., a medical technology company, engages in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled cooling technology to selectively reduce stubborn fat bulges. ZELTIQ Aesthetics, Inc. sells its products through a direct sales force, as well as through a network of distributors to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetic...
4698 Willow Road
Pleasanton, CA 94588
Founded in 2005
ZELTIQ Aesthetics, Inc. Announces Resignation of Jean George as Director
Jul 30 15
On July 27, 2015, Jean George, a director of ZELTIQ Aesthetics, Inc., resigned as a director, effective immediately.
ZELTIQ Aesthetics, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Revises Full Year 2015 Financial Guidance
Jul 30 15
ZELTIQ Aesthetics, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenues of USD 64,431,000 compared to USD 47,061,000 a year ago, total revenue cycles shipped increased 52% to 252,642 for the second quarter 2015, compared to 166,116 for the second quarter 2014. Income from operations was USD 1,653,000 compared to USD 2,765,000 a year ago. Income before income taxes was USD 1,221,000 compared to USD 2,696,000 a year ago. Net income was USD 1,178,000 or USD 0.03 per basic and diluted share compared to USD 2,769,000 or USD 0.07 per basic and diluted share a year ago. Adjusted EBITDA was USD 5,286,000 compared to USD 5,647,000 a year ago.
For the six months, the company reported revenues of USD 115,989,000 compared to USD 78,036,000 a year ago. Loss from operations was USD 41,000 compared to USD 4,446,000 a year ago. Loss before income taxes was USD 880,000 compared to USD 4,562,000 a year ago. Net loss was USD 951,000 or USD 0.02 per basic and diluted share compared to USD 4,568,000 or USD 0.12 per basic and diluted share a year ago. Net cash provided by operating activities was USD 7,230,000 compared to net cash used in operating activities of USD 10,331,000 a year ago. Purchase of property and equipment was USD 1,188,000 compared to USD 770,000 a year ago. Adjusted EBITDA was USD 8,254,000 compared to USD 997,000 a year ago.
The company revised full year 2015 financial guidance. For the year, the company revenue guidance in the range of USD 245 million to USD 247 million which includes approximately USD 3 million of currency headwinds; up from prior guidance of USD 235 million to USD 238 million. Consumable revenue of approximately 50% of total revenue; unchanged from prior guidance. Gross profit margin of approximately 71% of total revenue; unchanged from prior guidance. Operating expenses in the range of 69% to 70% of total revenue; down from prior guidance of approximately 70%. Stock-based compensation, depreciation, and amortization expense of approximately 7% of total revenue; unchanged from prior guidance. Adjusted EBITDA margin in the range of 8% to 9% of total revenue; up from prior guidance of approximately 8%.
ZELTIQ Aesthetics, Inc. to Report Q2, 2015 Results on Jul 30, 2015
Jul 16 15
ZELTIQ Aesthetics, Inc. announced that they will report Q2, 2015 results at 1:30 PM, Pacific Standard Time on Jul 30, 2015